Counsyl, a South San Francisco, Calif.-based provider of a platform that gives people access to information about their bodies, raised $28m in Series D financing.
The round was led by Rosemont Seneca Technology Partners and Goldman Sachs Asset Management.
The company, which has now raised $93m, will use the funds to continue to invest in product development.
Led by Ramji Srinivasan, co-founder and Chief Executive Officer, and Rishi Kacker, co-founder and VP of engineering, Counsyl provides a comprehensive platform for people to request and receive health information in two weeks or less. It uses custom-built robots to process blood and saliva samples working alongside a team of scientists and engineers to simultaneously analyze thousands of DNA samples with precision, accuracy and unparalleled efficiency.
The company has just launched the Inherited Cancer Screen starting with cancer susceptibility genes BRCA1 and BRCA2 and is advancing its Family Prep Screen using the latest in sequencing technology for couples planning to start a family.
It has also announced Counsyl Complete, a platform for online communication of results between physicians and patients.
FinSMEs
11/05/2014